156 related articles for article (PubMed ID: 8203841)
1. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
[TBL] [Abstract][Full Text] [Related]
2. Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.
Lemaitre BC; Mazigh DA; Scavizzi MR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1785-90. PubMed ID: 1952849
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
[TBL] [Abstract][Full Text] [Related]
5. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
[TBL] [Abstract][Full Text] [Related]
6. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
Louie A; Deziel MR; Liu W; Drusano GL
Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
Frean JA; Arntzen L; Capper T; Bryskier A; Klugman KP
Antimicrob Agents Chemother; 1996 Nov; 40(11):2646-7. PubMed ID: 8913481
[TBL] [Abstract][Full Text] [Related]
8. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
[TBL] [Abstract][Full Text] [Related]
10. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
[TBL] [Abstract][Full Text] [Related]
11.
Steenbergen J; Tanaka SK; Miller LL; Halasohoris SA; Hershfield JR
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223382
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
Hernandez E; Girardet M; Ramisse F; Vidal D; Cavallo JD
J Antimicrob Chemother; 2003 Dec; 52(6):1029-31. PubMed ID: 14613959
[TBL] [Abstract][Full Text] [Related]
13. Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of
Willix JL; Stockton JL; Olson RM; Anderson PE; Anderson DM
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015027
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
[TBL] [Abstract][Full Text] [Related]
15. Plasmid-mediated doxycycline resistance in a Yersinia pestis strain isolated from a rat.
Cabanel N; Bouchier C; Rajerison M; Carniel E
Int J Antimicrob Agents; 2018 Feb; 51(2):249-254. PubMed ID: 29030266
[TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
[TBL] [Abstract][Full Text] [Related]
17. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice.
Russell P; Eley SM; Bell DL; Manchee RJ; Titball RW
J Antimicrob Chemother; 1996 Apr; 37(4):769-74. PubMed ID: 8722542
[TBL] [Abstract][Full Text] [Related]
18. Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.
Scavizzi MR; Alonso JM; Philippon AM; Jupeau-Vessieres AM; Guiyoule A
Antimicrob Agents Chemother; 1987 Apr; 31(4):523-6. PubMed ID: 3475033
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.
Louie A; Vanscoy B; Liu W; Kulawy R; Brown D; Heine HS; Drusano GL
Antimicrob Agents Chemother; 2011 Jun; 55(6):2623-8. PubMed ID: 21486959
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
